[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100332108":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":25,"locations":34,"responsibleParty":51,"collaborators":55,"id":83,"slug":84,"hasResults":85,"nctId":86,"briefTitle":87,"officialTitle":88,"acronym":10,"eligibilityCriteria":89,"healthyVolunteers":85,"sex":90,"minAge":91,"maxAge":10,"enrollmentInfo":92,"targetDuration":10,"studyType":95,"phases":10,"briefSummary":96,"conditions":97,"keywords":99,"overallStatus":36,"whyStopped":10,"lastUpdateSubmitDate":103,"lastUpdatePostDateStruct":104,"startDateStruct":107,"completionDateStruct":109,"leadSponsor":111,"locationsCount":112},{"fullName":5,"class":6},"Guangzhou 8th People's Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Lpv\u002Fr+3TC",null,"These cases were given simplified therapy regimen including lopinavir(200mg) and ritonavir(50mg)500 mg,oral,bid) combined with lamivudine (300 mg,oral,qd).",[13],"Drug: Lpv\u002Fr+3TC",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"DRUG","It is a simplified therapy regimen study of lopinavir and ritonavir combined with lamivudine for HIV-1 infected patients in the real world of China.",[9],[20],"A simplified therapy regimen",[22],{"name":23,"affiliation":5,"role":24},"Weiping Cai, Bachelor","STUDY_CHAIR",[26,31],{"name":27,"role":28,"phone":29,"phoneExt":10,"email":30},"Linghua Li, Doctor","CONTACT","020-83710825","llheliza@126.com",{"name":23,"role":28,"phone":32,"phoneExt":10,"email":33},"020-83710816","gz8hcwp@126.com",[35],{"facility":5,"status":36,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"RECRUITING","Guangzhou","Guangdong","510060","China","CN",{"type":43,"coordinates":44},"Point",[45,46],113.25,23.11667,{"lat":46,"lon":45},[49,50],{"name":27,"role":28,"phone":29,"phoneExt":10,"email":30},{"name":23,"role":28,"phone":32,"phoneExt":10,"email":33},{"type":52,"investigatorFullName":53,"investigatorTitle":54,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Linghua LI","Vice Chief physician",[56,59,61,63,65,67,69,71,73,75,77,79,81],{"name":57,"class":58},"Guiyang Public Health Clinical Center","UNKNOWN",{"name":60,"class":58},"The Third People's Hospital of Kunming",{"name":62,"class":58},"The Second People's Hospital of Nanjing",{"name":64,"class":6},"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",{"name":66,"class":58},"The Third People's Hospital of Guilin",{"name":68,"class":58},"Guangxi Longtan hospital",{"name":70,"class":6},"The Fourth People's Hospital of Nanning",{"name":72,"class":6},"LiuZhou People's Hospital",{"name":74,"class":6},"Tianjin Second People's Hospital",{"name":76,"class":6},"Shenyang Sixth People's Hospital",{"name":78,"class":58},"The Sixth People's Hospital of Henan",{"name":80,"class":58},"The Sixth People's Hospital of Xinjiang",{"name":82,"class":58},"The Eighth People's Hospital of Xi'an","100332108","simplified-treatment-of-anti-retrovirus-in-china-c-star-100332108",false,"NCT03603977","Simplified Treatment of Anti-retrovirus in China (C-STAR)","A Simplified Therapy Regimen Study of Lopinavir and Ritonavir Combined With Lamivudine for HIV-1 Infected Patients in the Real World of China","Inclusion Criteria:\n\n1. HIV-1 infection confirmed\n2. Agree to use simplified therapy regimen.\n3. Agree to detect CD4 count at least once per half a year\n\nExclusion Criteria:\n\n1. Have participated in HIV vaccine clinical trial or other drug trials in the past three months.\n2. Patients who could not complete the scheduled follow-up (such as weakness and poor compliance).\n3. Patients who have the history of resistance or allergy to LPV\u002Fr or 3TC.","ALL","18 Years",{"count":93,"type":94},600,"ESTIMATED","OBSERVATIONAL","To observe the efficacy and safety of simplified therapy regimen for treating with HIV-1 infected patients in Chinese real word.",[98],"HIV\u002FAIDS",[100,101,102],"Simplified Therapy Regimen","Real World Study","HIV-1-infected patients","2022-09-13",{"date":105,"type":106},"2022-09-14","ACTUAL",{"date":108,"type":106},"2017-11-01",{"date":110,"type":94},"2030-10-31",{"name":5,"class":6},1]